Sage Therapeutics, Inc. (SAGE)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
As of 09:42AM EDT. Market open.
| Previous Close | 12.39 |
| Open | 12.39 |
| Bid | 12.23 x 200 |
| Ask | 12.46 x 200 |
| Day's Range | 12.23 - 12.39 |
| 52 Week Range | 10.92 - 59.99 |
| Volume | |
| Avg. Volume | 1,071,142 |
| Market Cap | 745.655M |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.39 |
| Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.88 |
Business WireSage Therapeutics to Participate in Upcoming May Investor Conferences
CAMBRIDGE, Mass., May 07, 2024--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in the following upcoming investor conferences in May:
Insider MonkeySage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
Simply Wall St.Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates
Investors in Sage Therapeutics, Inc. ( NASDAQ:SAGE ) had a good week, as its shares rose 2.7% to close at US$13.69...
© 2024 Yahoo. All rights reserved.